Literature DB >> 2917074

Desmoplastic melanoma. Histologic correlation with behavior and treatment.

S Beenken1, R Byers, J L Smith, H Goepfert, R Shallenberger.   

Abstract

Desmoplastic (neurotrophic) melanoma is a histologic variant of cutaneous melanoma that has a distinct clinical behavior. To better understand this behavior and to treat the disease more effectively, the medical records of 16 patients treated for this disease over a 12-year period were reviewed. Thirteen patients had head and neck lesions, the ear being a common site. The average thickness of the lesions was 5.75 mm. Six (46.2%) of 13 patients had local recurrence of disease. Only two patients (15.4%) developed regional node metastases. None of the patients with clinically NO desmoplastic melanoma were found to have positive nodes after elective neck dissection, regardless of the thickness of the primary lesion. Wide excision of the primary lesion with frozen section control of surgical margins and careful examination for the presence of perineural invasion is important in determining the extent of surgical resection.

Entities:  

Mesh:

Year:  1989        PMID: 2917074     DOI: 10.1001/archotol.1989.01860270116025

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

1.  Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick.

Authors:  J Gregory McKinnon; Emma C Starritt; Richard A Scolyer; William H McCarthy; John F Thompson
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

2.  Desmoplastic melanoma: patterns of recurrence.

Authors:  B M Smithers; G R McLeod; J H Little
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

Review 3.  Malignant melanoma with neural differentiation: an exceptional case report and brief review of the pertinent literature.

Authors:  Albert Su; Sarah M Dry; Scott W Binder; Jonathan Said; Peter Shintaku; G Peter Sarantopoulos
Journal:  Am J Dermatopathol       Date:  2014-01       Impact factor: 1.533

4.  Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma.

Authors:  William G Rule; Jacob B Allred; Barbara A Pockaj; Svetomir N Markovic; David J DiCaudo; Lori A Erickson; Richard L Deming; Steven E Schild
Journal:  Cancer Med       Date:  2016-07-01       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.